BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Immunology

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

February 04, 2022 | News

Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa

In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...

February 01, 2022 | News

Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer

Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...

January 24, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...

January 04, 2022 | News

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...

December 29, 2021 | News

Regor Therapeutics announced authorization from the USFDA to proceed with Regor's Phase 1 clinical development plans for RGT-419B.

On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration ...

December 28, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

Clarity and Cardinal Health to address the growing needs in oncology

Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...

December 03, 2021 | News

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

Africa to benefit from advanced radiation therapy for cancer patients

Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCE...

November 26, 2021 | News

Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment

Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component ...

November 17, 2021 | News

Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment

Singapore-based viral vector CDMO supplies lentiviruses to Carina Biotech, advancing first in-human clinical trial for bowel cancer treatment ...

November 10, 2021 | News

Veracyte Announces Immunoscore Colon Cancer Test

Veracyte, Inc. today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guideli...

November 08, 2021 | News

Stay Connected